Genomic Approaches for Target Validation in Heart Failure

01 Dec 2020, December 1, 2020 Eastern Time (ET)

In this webinar you will learn:

• How whole genome sequencing, and deep phenotyping combine to guide all stages of drug development
• The value of investigating pre-symptomatic, stage B heart failure and its subtypes to understand disease mechanisms and genetic drivers of early heart failure with preserved and reduced ejection fraction
• How the intersection of population-scale data, robust software tools, and analytical expertise accelerate insight in common, complex disease